Zhang Wenyao, Wang Lixue, Demna Mohamed Yassine, Xiong Jialong, Luo Maoguo, Wang Yanfeng, Wang Feng
Key Laboratory of Molecular Medicine and Biotherapy, School of Life Science, Beijing Institute of Technology, Beijing 100081, China.
College of Animal Sciences, Zhejiang University, Hangzhou 310058, China.
Biomedicines. 2025 Sep 8;13(9):2194. doi: 10.3390/biomedicines13092194.
MicroRNAs (miRNAs), as an integral component of gene regulatory networks, play a critical role in post-transcriptional regulation, maintaining a dynamic balance between miRNA biogenesis and turnover essential for maintaining cellular homeostasis. The regulation of miRNA turnover, particularly through target-directed microRNA degradation (TDMD), is emerging as a key mechanism in gene expression control in response to physiological, developmental, and environmental changes. This process is mediated by the ubiquitin-proteasome system (UPS), where the E3 ligase ZSWIM8 functions as an adaptor to facilitate the recognition and degradation of Argonaute (AGO) proteins, essential components of the miRNA-induced silencing complex (miRISC), thus negatively regulating gene expression. The ZSWIM8-UPS axis contributes to the precise modulation of miRNA levels by targeting AGO proteins for degradation, thereby influencing miRNA stability and function. This review summarizes the mechanisms underlying ZSWIM8-mediated TDMD, its molecular interactions, and the potential therapeutic applications of targeting miRNA turnover pathways. By understanding the regulation of miRNA degradation, we aim to inform future strategies for the clinical manipulation of miRNA-based therapeutics.
微小RNA(miRNA)作为基因调控网络的一个组成部分,在转录后调控中发挥着关键作用,维持miRNA生物合成与周转之间的动态平衡对于维持细胞内稳态至关重要。miRNA周转的调控,尤其是通过靶向性微小RNA降解(TDMD)进行的调控,正逐渐成为响应生理、发育和环境变化时基因表达控制的关键机制。这个过程由泛素-蛋白酶体系统(UPS)介导,其中E3连接酶ZSWIM8作为衔接子,促进对Argonaute(AGO)蛋白的识别和降解,AGO蛋白是miRNA诱导沉默复合体(miRISC)的重要组成部分,从而对基因表达进行负调控。ZSWIM8-UPS轴通过靶向AGO蛋白进行降解,有助于精确调节miRNA水平,进而影响miRNA的稳定性和功能。本综述总结了ZSWIM8介导的TDMD的潜在机制、其分子相互作用以及靶向miRNA周转途径的潜在治疗应用。通过了解miRNA降解的调控机制,我们旨在为基于miRNA的治疗方法的临床应用提供未来策略。